'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

Bibliographische Detailangaben
Veröffentlicht in:Manila Bulletin Vol. 584, no. 7 (07 Aug. 2021), 2
1. Verfasser: Luci, Charissa M.
Format: Artikel
Veröffentlicht: 2021
Schlagworte:
Molnupiravir (Antiviral drug)
Clinical trials > Lung Center of the Philippines
COVID-19 treatment